Latin America Pharmaceutical Contract Manufacturing Organization Market Share

Market Share of Latin America Pharmaceutical Contract Manufacturing Organization Industry

The Latin America pharmaceutical contract manufacturing organization market is moderately fragmented and is moving towards highly fragmented market. Vendors are expanding across regions and are forming strategic and collaborative initiatives with companies to increase their market share and their profitability. Some of the recent developments in the market are:

• February 2020 - Catalent, signed an agreement with Zumutor Biologics, Inc., to manufacture Zumutor's, ZM008, for the treatment of solid tumors. Zumutor is a biologics company that develops novel immuno-oncotherapeutics to drive transformational improvements in cancer treatment.
• June 2019 - Lonza announced an investment at its Visp site, a HPAPI facility, to meet the increased market demand. Its expertise in HPAPI development and manufacturing, along with particle engineering and finished drug products, is aimed at oral and parenteral applications. The addition of two 4 m3 scale, multi-purpose production lines for HPAPI manufacturing extended the production capacities from lab to a large commercial scale.

Latin America Pharmaceutical Contract Manufacturing Organization Market Leaders

1. Catalent Inc.

2. Jubilant Life Sciences Ltd

3. Boehringer Ingelheim Group

4. Pfizer CentreSource (Pfizer Inc)

5. Thermo Fisher Scientific Inc. (Patheon Inc.)

*Disclaimer: Major Players sorted in no particular order